General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Novartis(MODEST), Merck(MODEST), Bayer Healthcare Pharmaceuticals(MODEST), Tenaya(MODEST), Ionis(MODEST), Tenaya(MODEST), Affinia(MODEST), Astellas Pharma US(MODEST), AstraZeneca Pharmaceuticals(MODEST), Bristol-Myers Squibb Company (MODEST) RESEARCH/RESEARCH GRANTS: Rocket Pharma(NONE) OTHER FINANCIAL BENEFIT: ACI(SIGNIFICANT)

View Full Disclosure